131 related articles for article (PubMed ID: 2582585)
1. Rate-dependent changes in intraventricular conduction produced by procainamide in anesthetized dogs. A quantitative analysis based on the relation between phase 0 inward current and conduction velocity.
Nattel S; Jing W
Circ Res; 1989 Dec; 65(6):1485-98. PubMed ID: 2582585
[TBL] [Abstract][Full Text] [Related]
2. A quantitative analysis of use-dependent ventricular conduction slowing by procainamide in anesthetized dogs.
Villemaire C; Savard P; Talajic M; Nattel S
Circulation; 1992 Jun; 85(6):2255-66. PubMed ID: 1317275
[TBL] [Abstract][Full Text] [Related]
3. Modulation of procainamide's effect on cardiac conduction in dogs by extracellular potassium concentration. A quantitative analysis.
Villemaire C; Nattel S
Circulation; 1994 Jun; 89(6):2870-8. PubMed ID: 8205703
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of procainamide-induced rate-dependent conduction slowing by elevated myocardial extracellular potassium concentration in vivo.
Cascio WE; Foster JR; Buchanan JW; Johnson TA; Gettes LS
Circulation; 1987 Dec; 76(6):1380-7. PubMed ID: 3677360
[TBL] [Abstract][Full Text] [Related]
5. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.
Nattel S
J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790
[TBL] [Abstract][Full Text] [Related]
6. The effects of procainamide on conduction in anisotropic canine ventricular myocardium.
Kadish AH; Spear JF; Levine JH; Moore EN
Circulation; 1986 Sep; 74(3):616-25. PubMed ID: 3742759
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of procainamide, lidocaine and acetylstrophanthidin on body surface potentials and epicardial conduction in dogs with chronic myocardial infarction.
de Langen CD; Hanich RF; Michelson EL; Kadish AH; Levine JH; Balke CW; Spear JF; Moore EN
J Am Coll Cardiol; 1988 Feb; 11(2):403-13. PubMed ID: 3339181
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of use-dependent ventricular conduction slowing by antiarrhythmic drugs in humans.
Ranger S; Talajic M; Lemery R; Roy D; Villemaire C; Nattel S
Circulation; 1991 Jun; 83(6):1987-94. PubMed ID: 2040051
[TBL] [Abstract][Full Text] [Related]
9. Circus movement atrial flutter in the canine sterile pericarditis model. Differential effects of procainamide on the components of the reentrant pathway.
Schoels W; Yang H; Gough WB; el-Sherif N
Circ Res; 1991 Apr; 68(4):1117-26. PubMed ID: 2009611
[TBL] [Abstract][Full Text] [Related]
10. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.
Wang J; Bourne GW; Wang Z; Villemaire C; Talajic M; Nattel S
Circulation; 1993 Sep; 88(3):1030-44. PubMed ID: 8353865
[TBL] [Abstract][Full Text] [Related]
11. Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects.
Kirchhof PF; Fabritz CL; Franz MR
Circulation; 1998 Jun; 97(25):2567-74. PubMed ID: 9657478
[TBL] [Abstract][Full Text] [Related]
12. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
[TBL] [Abstract][Full Text] [Related]
13. Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effects of lidocaine in the intact canine heart.
Anderson KP; Walker R; Lux RL; Ershler PR; Menlove R; Williams MR; Krall R; Moddrelle D
Circulation; 1990 Mar; 81(3):1024-38. PubMed ID: 2155070
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
[TBL] [Abstract][Full Text] [Related]
15. Effects of procainamide and propafenone on the composition of the excitable gap in canine atrial reentry tachycardia.
Derakhchan K; Pagé P; Lambert C; Kus T
J Pharmacol Exp Ther; 1994 Jul; 270(1):47-54. PubMed ID: 8035342
[TBL] [Abstract][Full Text] [Related]
16. Selective depression of conduction of premature action potentials in canine Purkinje fibres by class Ib antiarrhythmic drugs: comparison with Ia and Ic drugs.
Pallandi RT; Campbell TJ
Cardiovasc Res; 1988 Mar; 22(3):171-8. PubMed ID: 3167941
[TBL] [Abstract][Full Text] [Related]
17. Modulation of procainamide's effect on conduction by cellular uncoupling in perfused rabbit hearts.
Spear JF; Hook BG; Josephson ME; Moore EN
J Cardiovasc Electrophysiol; 1997 Feb; 8(2):199-214. PubMed ID: 9048250
[TBL] [Abstract][Full Text] [Related]
18. The effects of antiarrhythmic drugs, stimulation frequency, and potassium-induced resting membrane potential changes on conduction velocity and dV/dtmax in guinea pig myocardium.
Buchanan JW; Saito T; Gettes LS
Circ Res; 1985 May; 56(5):696-703. PubMed ID: 3995697
[TBL] [Abstract][Full Text] [Related]
19. Rate-dependent effects of procainamide on His-Purkinje conduction in man.
Gang ES; Denton TA; Oseran DS; Mandel WJ; Peter T
Am J Cardiol; 1985 Jun; 55(13 Pt 1):1525-9. PubMed ID: 4003294
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of electrocardiographic changes with some representative antiarrhythmic drugs in adult rats.
Suzuki J; Tsubone H; Sugano S
J Vet Med Sci; 1991 Oct; 53(5):779-87. PubMed ID: 1836364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
